Article

Hexane/ethanol extract of Glycyrrhiza uralensis licorice suppresses doxorubicin-induced apoptosis in H9c2 rat cardiac myoblasts.

Department of Food Science and Nutrition, Hallym University, Chuncheon 200-702, South Korea.
Experimental Biology and Medicine (Impact Factor: 2.23). 11/2008; 233(12):1554-60. DOI: 10.3181/0807-RM-221
Source: PubMed

ABSTRACT Doxorubicin (DOX) is an anthracycline antibiotic, and has been recognized as one of the most effective anti-neoplastic agents in cancer chemotherapy. However, its usefulness is limited by its profound cardiotoxicity. Licorice is one of the most frequently prescribed agents in traditional herbal medicine, and is also employed as a natural sweetening additive. In traditional Chinese medicine, licorice root is added to a variety of herbal preparations to detoxify the effects of the other herbs in the preparation. In the present study, we explored the possibility that Glycyrrhiza uralensis licorice may alleviate DOX-induced cardiotoxicity. The hexane/ethanol extract of Glycyrrhiza uralensis (HEGU), which lacks glycyrrhizin, was prepared because glycyrrhizin intake has previously been reported to induce hypertension. In an effort to determine whether HEGU ameliorates DOX-induced cytotoxicity in H9c2 rat cardiac myoblasts, the cells were pretreated with 0-15 mg/L HEGU, then treated with doxorubicin. The pretreatment of cells with HEGU resulted in a significant mitigation of DOX-induced reductions in cell numbers (34 +/- 7%) and increases in apoptosis (53 +/- 1%). The Western blot analysis of cell lysates showed that HEGU suppressed DOX-induced increases in the levels of p53, phospho-p53 (Ser 15), and Bax. In addition, HEGU induced an increase in the levels of Bcl-xL, regardless of DOX-treatment. HEGU inhibited the DOX-induced cleavage of caspases 9, 3, and 7, as well as DOX-induced poly(ADP-ribose) polymerase cleavage. Furthermore, HEGU caused reductions in the viable cell numbers of HT-29 human colon cancer cells (IC50 = 10.7 +/- 0.3 mg/L), MDA-MB-231 human breast cancer cells (IC50 = 7.5 +/- 0.1 mg/L), and DU145 human prostate cancer cells (IC50 = 4.7 +/- 0.5 mg/L). HEGU augmented DOX-induced reductions in the viability of DU145 cells (15 +/- 1%). These results indicate that HEGU may potentially be an effective agent for the alleviation of DOX-induced cardiotoxicity.

Download full-text

Full-text

Available from: Jong-Sang Kim, Apr 15, 2014
1 Follower
 · 
135 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Glycyrrhiza uralensis Fisch is an important medicinal plant used not only as a natural sweetener but also for a variety of pharmaceutical applications. Even though there have been previous reports of genes putatively associated with the biosynthesis of the sweet compound glycyrrhizin, the absence of genomic information and the insufficient transcriptomic data for this plant still hinder sufficient insight into the causative genes underlying the pharmaceutical and culinary applications of Glycyrrhiza uralensis Fisch. In this study, we sequenced 5,276 ESTs from Glycyrrhiza uralensis Fisch, established 2,353 unique sequences based on clustering and performed comparative analysis of them. Of the 2,353 unique sequences, we found homologs and orthologs for 1,499 of them with similarity searches against the non-redundant protein database at NCBI using the BLASTX algorithm and against the InterPro database using hidden Markove model (HMM) methods. We have functionally classified 749 unique sequences using Gene Ontology (GO) terms, mapped pathways for 248 unique sequences with the Kyoto Encyclopedia of Genes and Genomes (KEGG) and predicted 30 secreted proteins. Based on their expression levels, we have identified genes encoding a novel beta-D-xylosidase, glutathione-S-transferase and arabinogalactan protein 16 that may function in the glycyrrhizin biosynthesis, anti-tumor activity and detoxifying activity of this very promising medicinal plant. Furthermore, the EST sequence information described in this paper could be a valuable resource for future scientific research projects on this plant, including genome sequencing and annotation and genetic diversity as well as functional genomics and molecular functional studies. KeywordsGlycyrrhiza uralensis Fisch–glycyrrhizin–Pharmaceutical application–EST
    Plant Molecular Biology Reporter 12/2011; 29(4):814-824. DOI:10.1007/s11105-011-0290-9 · 2.37 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Previously, we prepared a hexane/ethanol extract of Glycyrrhiza uralensis (HEGU) containing undetectable amounts of glycyrrhizin, which is known to induce hypertension. This study assessed the effect of HEGU on inflammatory responses in lipopolysaccharide (LPS)-treated Raw264.7 macrophages and in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate. In the LPS-stimulated macrophages, HEGU (0–2 μg/ml) reduced nitric oxide (NO) release and the protein expression and transcriptional activity of inducible NO synthase (iNOS). HEGU reduced prostaglandin E2 release and phospholipase A2 transcripts. HEGU reduced the secretion and mRNA levels of tumour necrosis factor-α, interleukin (IL)-6, and IL-1β. HEGU prevented IκBα degradation, p65 nuclear translocation, NFκB DNA binding and transcriptional activities. Additionally, dehydroglyasperin C, isolated from HEGU, reduced NO production, iNOS expression, and NFκB transcriptional activity. In the mouse inflammation model, HEGU suppressed skin swelling and iNOS and cyclooxygenase-2 expression. These results indicate that HEGU exerts powerful anti-inflammatory effects, probably mediated via the inhibition of NFκB signalling.
    Food Chemistry 08/2010; DOI:10.1016/j.foodchem.2010.01.027 · 3.26 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Glycyrrhiza uralensis (licorice) is one of the most frequently prescribed ingredients in Oriental medicine, and licorice extract has been shown to exert anti-carcinogenic effects. However, its use as a cancer chemopreventive agent is rather limited, due to the fact that its principal component, glycyrrhizin, is known to induce hypertension. This study determined the effects of a hexane/ethanol extract of G. uralensis (HEGU), which contains undetectable amounts of glycyrrhizin, on the apoptosis of androgen-insensitive DU145 cells. HEGU induced apoptosis and increased the levels of cleaved caspase-9, caspase-7, caspase-3 and poly (ADP-ribose) polymerase (PARP). HEGU also induced mitochondrial membrane depolarization and cytochrome c release to the cytosol. HEGU increased the levels of Fas, death receptor 4 (DR4), cleaved caspase-8, Mcl-1S, and truncated Bid proteins. A caspase-8 inhibitor suppressed HEGU-induced apoptosis. An active fraction of HEGU was separated via column chromatography and the structure of the active compound isoangustone A was identified via 1H-NMR and 13C-NMR. Isoangustone A increased apoptotic cells, the cleavage of PARP and caspases, and the levels of DR4 and Mcl-1S. Transfection with DR4 small interfering RNA attenuated HEGU- and isoangustone A-induced apoptosis. These results demonstrate that the activation of DR4 contributes to HEGU- and isoangustone A-induced apoptosis of DU145 cells.
    Molecular Nutrition & Food Research 09/2010; 54(9):1329-39. DOI:10.1002/mnfr.200900260 · 4.91 Impact Factor